Optimization of a micro-high-performance liquid chromatography method for determination of metronidazole benzoate in their standard powder and in dosage pharmaceuticals

H. N. K. AL-Salman

Abstract


Context: In this manuscript, a high-performance liquid chromatography (HPLC) method for the determination of
metronidazole in pharmaceuticals was described and developed. Methods: The reversed-phase HPLC (RP-HPLC)
method was developed and the results obtained to determine the form of metronidazole. Chromatographic analysis
was performed in HPLC-ultraviolet (HPLC-UV) system with Ion Pac column; Arcus EP-C18; 5 μm, 4.6 mm×
250 mm, with acetonitrile: triethylamine 30:70 (v/v)+0.5 M potassium dihydrogen orthophosphate buffer at
pH 4.5 as mobile phase, at a flow rate of 1.0 ml/min. UV detection in HPLC system was performed at 310 nm.
Results: The method was validated for accuracy, precision, specificity, linearity, and sensitivity. The retention
time for the metronidazole was 9.9 min. Calibration plots were linear over the concentration ranges 1–5 μg/L
for the metronidazole. The limit of detection was 0.115 μg/ml and the limit of quantitation was 0.437 μg/ml.
The accuracy of the proposed method was determined by recovery studies and found to be from 93.3% to 100%.
Conclusion: Commercial tablet formulation was successfully analyzed using the developed HPLC-UV method
that has been validated; accuracy, precision, and specificity were found to be within the acceptable limits. Moreover,
results obtained by the suggested methods showed no significant difference between the results obtained from the
suggested method.


Full Text:

PDF


DOI: http://dx.doi.org/10.22377/ijgp.v13i01.2335

Refbacks

  • There are currently no refbacks.